Impax Lab Cash Flow - Quarterly (NASDAQ:IPXL)

Add to My Stocks
$20.05 $0.4 (1.96%) IPXL stock closing price Mar 20, 2018 (Closing)

The financial analysis of IPXL requires an investor to check the cash flows for Impax Lab. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Impax Lab profits one has to check the income statement and for Impax Lab debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in Impax Lab stock analysis. Impax Lab had a negative net income cash flow of $-168.21M till this quarter of 2017 Q3. This report is very useful in measuring the short term viability of a company. Impax Lab has a negative cash and cash equivalents change of $-22.47M.

View and download details of Impax Lab cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow85.37M53.96M25.75M88.34M63.1M36.41M15.72M68.63M48.66M
Net Increase (Decrease) in Assets Liabilities-18.07M22.65M20.69M-2.43M-22.25M-11.65M44.28M-70.18M-35.35M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net147.72M100.41M91.79M460.71M249.37M12.12M27.86M34.47M-5.8M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-15.07M-18.64M-8.67M-48.04M-30.51M-19.16M-10.88M-25.19M-14.7M
Acquisition Disposition of Subsidiaires----585.8M-585.8M---691.34M-691.34M
Increase (Decrease) in Investments----4.75M---195.31M200.06M
Other Cash Inflow (Outflow) from Investment Activities11.85M11.85M-11.5M11.5M11.5M-3.5M53.69M53.99M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares---9.23M9.13M9.17M7.66M99.79M99.24M
Issuance (Repayment) of Debt Securities-65M-60M-55M395M400M--600M600M
Increase (Decrease) in Bank & Other Borrowings---------
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-3.48M-2.7M-1.26M-12.45M-11.36M---178.4M-178.72M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash1.04M1.45M1.56M-1.04M---0.29M-0.07M
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year340.35M214.87M184.61M142.16M104.41M91.79M31.77M69.27M37.46M
Cash & Equivalents at Year End157.65M171.39M157.25M180.13M232.12M366.84M412.17M340.35M318.4M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The Impax Lab stock price history and Impax Lab stock comparison chart inevitably reflect its cash flow situation.

  • Impax Lab saw a negative change in Net Change in Cash and Cash Equivalents of $-22.47M till 2017 Q3. Apart from the Impax Lab stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Impax Lab increased its cash from operating activities to $46.8M till 2017 Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-2.69M for IPXL till last quarter 2017 Q3 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Impax Lab spent $-67.63M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Impax Lab Cash Flow

FCF margin

Quarterly Cash Flow Statements For Impax Laboratories Inc Peers

Akorn cash flow, Lipocine cash flow, Novartis cash flow, Supernus Pharma cash flow, Valeant cash flow